WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gary P. FischettiDirector2026-08-041,000$20.32
$20.32kBuy
Gary P. FischettiDirector2026-08-031,000$20.75
$20.75kBuy
Stephen D. GriffinPresident and CEO2026-06-033,769$14.41
$54.31kSell
John B. Henneman IiiDirector2026-05-015,000$14.66
$73.32kBuy
Stephen D. GriffinPresident and CEO2026-04-3012,200$12.29
$149.88kBuy
Ian McLeodSVP CAO Treasurer2026-03-15781$14.20
$11.09kSell
Cheryl R. BlanchardDirector2026-03-1512,104$14.20
$171.88kSell
David ColleranEVP General Counsel Corp Sec2026-03-151,893$14.20
$26.88kSell
Cheryl R. BlanchardDirector2026-03-1414,728$14.20
$209.14kSell
David ColleranEVP General Counsel Corp Sec2026-03-144,168$14.20
$59.19kSell

1 of 2

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc11.92%1,594,893$32.98MInstitution
Caligan Partners LP10.72%1,435,130$29.68MInstitution
Farmaceutici Spa Fidia10.63%1,422,384$29.41MInsider
Morgan Stanley6.52%872,066$18.03MInstitution
Acadian Asset Management LLC4.53%606,544$12.54MInstitution
Vanguard Capital Management LLC4.53%605,777$12.53MInstitution
Boothbay Fund Management LLC3.96%529,503$10.95MInstitution
Renaissance Technologies LLC3.75%502,217$10.39MInstitution
Dimensional Fund Advisors LP3.43%458,847$9.49MInstitution
Capital Management Corp3.35%447,721$9.26MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK81.27%18.73%Net SellingNet Selling
RXST74.46%25.54%Net Buying
TMCI44.31%55.69%Net BuyingNet Buying
PROF44.72%1.61%
RCEL96.83%3.17%Net BuyingNet Buying
View Top Medical Device Stocks

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 92.35% institutional shareholders, 21.29% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 10.63% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $30.20M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.